GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2020-04-06: Form 6-K; Period of report 2020-04-06; Description GSK AND VIR BIOTECHNOLOGY ENTER COLLABORATION; Document a9237i.htm.
- 2020-04-01: Form 6-K; Period of report 2020-04-01; Description GSK COMPLETES DIVESTMENT OF HORLICKS; Document a4364i.htm.
- 2020-04-01: Form 6-K; Period of report 2020-04-01; Description TOTAL VOTING RIGHTS; Document a4086i.htm.
- 2020-03-30: Form 6-K; Period of report 2020-03-30; Description CONSUMER HEALTHCARE PRODUCT SALES CATEGORY CHANGES; Document a1046i.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2020-04-06 | 6-K | 2020-04-06 | GSK AND VIR BIOTECHNOLOGY ENTER COLLABORATION | a9237i.htm |
| 2020-04-01 | 6-K | 2020-04-01 | GSK COMPLETES DIVESTMENT OF HORLICKS | a4364i.htm |
| 2020-04-01 | 6-K | 2020-04-01 | TOTAL VOTING RIGHTS | a4086i.htm |
| 2020-03-30 | 6-K | 2020-03-30 | CONSUMER HEALTHCARE PRODUCT SALES CATEGORY CHANGES | a1046i.htm |
| 2020-03-24 | 6-K | 2020-03-24 | PUBLICATION OF AGM NOTICE | a2929h.htm |
| 2020-03-20 | 6-K | 2020-03-20 | DIRECTORATE CHANGE | a0531h.htm |
| 2020-03-18 | 6-K | 2020-03-18 | DIRECTOR/PDMR SHAREHOLDING | a6481g.htm |
| 2020-03-13 | 6-K | 2020-03-13 | EMTN PROSPECTUS SUPPLEMENT UPDATE | a1760g.htm |
| 2020-03-11 | 6-K | 2020-03-11 | DIRECTOR/PDMR SHAREHOLDING | a8353f.htm |
| 2020-03-09 | 6-K | 2020-03-09 | DIRECTOR/PDMR SHAREHOLDING | a4903f.htm |
| 2020-03-09 | 6-K | 2020-03-09 | PUBLICATION OF GSK 2019 FORM 20-F | a3600f.htm |
| 2020-03-04 | 6-K | 2020-03-04 | ANNUAL FINANCIAL REPORT | a0299f.htm |
| 2020-03-02 | 6-K | 2020-03-02 | TOTAL VOTING RIGHTS | a6789e.htm |
| 2020-02-21 | 6-K | 2020-02-21 | DIRECTOR/PDMR SHAREHOLDING | a7805d.htm |
| 2020-02-20 | 6-K | 2020-02-20 | DIRECTOR/PDMR SHAREHOLDING | a6577d.htm |
| 2020-02-20 | 6-K | 2020-02-20 | DIRECTOR/PDMR SHAREHOLDING | a6481d.htm |
| 2020-02-20 | 6-K | 2020-02-20 | DIRECTOR/PDMR SHAREHOLDING | a6485d.htm |
| 2020-02-19 | 6-K | 2020-02-19 | DIRECTOR/PDMR SHAREHOLDING | a5248d.htm |
| 2020-02-19 | 6-K | 2020-02-19 | DIRECTOR/PDMR SHAREHOLDING | a5178d.htm |
| 2020-02-19 | 6-K | 2020-02-19 | DIRECTOR/PDMR SHAREHOLDING | a5186d.htm |
| 2020-02-19 | 6-K | 2020-02-19 | DIRECTOR/PDMR SHAREHOLDING | a5172d.htm |
| 2020-02-19 | 6-K | 2020-02-19 | DIRECTOR/PDMR SHAREHOLDING | a5163d.htm |
| 2020-02-12 | 6-K | 2020-02-12 | DIRECTOR/PDMR SHAREHOLDING | a8251c.htm |
| 2020-02-11 | 6-K | 2020-02-11 | DIRECTOR/PDMR SHAREHOLDING | a6646c.htm |
| 2020-02-11 | 6-K | 2020-02-11 | TRANSFER OF TREASURY SHARES | a5497c.htm |
| 2020-02-06 | 6-K | 2020-02-06 | DIRECTOR/PDMR SHAREHOLDING | a2545c.htm |
| 2020-02-05 | 6-K | 2020-02-05 | DIRECTOR/PDMR SHAREHOLDING | a1101c.htm |
| 2020-02-05 | 6-K | 2020-02-05 | FINAL RESULTS | a0670c.htm |
| 2020-02-03 | 6-K/A | 2020-02-03 | GSK PUBLISHES PROVISIONAL 2020 DIVIDEND DATES | a7971b.htm |
| 2020-02-03 | 6-K | 2020-02-03 | TOTAL VOTING RIGHTS | a7321b.htm |
| 2020-01-15 | 6-K | 2020-01-15 | DIRECTOR/PDMR SHAREHOLDING | a8062z.htm |
| 2020-01-14 | 6-K | 2020-01-14 | DIRECTOR/PDMR SHAREHOLDING | a7973z.htm |
| 2020-01-14 | 6-K | 2020-01-14 | DIRECTOR/PDMR SHAREHOLDING | a7924z.htm |
| 2020-01-13 | 6-K | 2020-01-13 | DIRECTOR/PDMR SHAREHOLDING | a6632z.htm |
| 2020-01-13 | 6-K | 2020-01-13 | DIRECTOR/PDMR SHAREHOLDING | a6176z.htm |
| 2020-01-13 | 6-K | 2020-01-13 | DIRECTOR/PDMR SHAREHOLDING | a6050z.htm |
| 2020-01-13 | 6-K | 2020-01-13 | DIRECTOR/PDMR SHAREHOLDING | a5969z.htm |
| 2020-01-08 | 6-K | 2020-01-08 | GSK ANNOUNCES ADDITION TO CORPORATE EXECUTIVE TEAM | a1928z.htm |
| 2020-01-08 | 6-K | 2020-01-08 | GSK PUBLISHES PROVISIONAL 2020 DIVIDEND DATES | a2044z.htm |
| 2020-01-02 | 6-K | 2020-01-02 | TOTAL VOTING RIGHTS | a5391y.htm |